Comparison of the grade evaluated by "Liver damage" of Liver Cancer Study Group of Japan and Child-Pugh classification in patients with hepatocellular carcinoma

Hepatology Research

Volumn 34, Issue 4, 2006, Pages 266-272

  Omagari, Katsuhisa ^a   Ohba, Kazuo ^a   Kadokawa, Yoshiko ^a   Hazama, Hiroaki ^a   Masuda, Jun Ichi ^a   Kinoshita, Hideki ^a   Matsuo, Isao ^a   Ohnita, Ken ^a   Mizuta, Yohei ^a   Hayashida, Kenji ^a   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

"Liver damage"; Child Pugh classification; Hepatocellular carcinoma; Indocyanine green

Indexed keywords

ALBUMIN; BILIRUBIN; INDOCYANINE GREEN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; ASCITES; BILIRUBIN BLOOD LEVEL; BRAIN DISEASE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; JAPAN; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER FUNCTION TEST; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTHROMBIN TIME; RETROSPECTIVE STUDY; SCORING SYSTEM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

EID: 33645035105     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hepres.2005.05.010     Document Type: Article

References (17)

1. K. Dohmen Many staging systems for hepatocellular carcinoma: Evolution from Child-Pugh, Okuda to SLiDe J Gastroenterol Hepatol 19 2004 1227-1232
2. The Cancer of the Liver Italian Program (CLIP) Investigators A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients Hepatology 28 1998 751-755
3. J.M. Llovet C. Bru J. Bruix Prognosis of hepatocellular carcinoma: The BCLC staging classification Semin Liver Dis 19 1999 329-338
4. M. Kudo H. Chung S. Haji et. al. Validation of a new prognostic staging system for hepatocellular carcinoma: The JIS score compared with the CLIP score Hepatology 40 2004 1396-1405
5. T. Kawakita K. Shiraki Y. Yamanaka et. al. A new prognostic scoring system involving des-γ-carboxy prothrombin as a useful marker for predicting prognosis in patients with hepatocellular carcinoma Int J Oncol 23 2003 1115-1120
6. R.N.H. Pugh I.M. Murray-Lyon J.L. Dawson M.C. Pietroni R. Williams Transection of the oesophagus for bleeding oesophageal varices Br J Surg 60 1973 646-649
7. E. Christensen Prognostic models including the Child-Pugh, MELD and Mayo risk scores-where are we and where should we go? J Hepatol 41 2004 344-350
8. L. Pagliaro MELD: The end of Child-Pugh classification? J Hepatol 36 2002 141-145
9. Liver Cancer Study Group of Japan The general rules for the clinical and pathological study of primary liver cancer 4th ed. 2000 Kanehara & Co., Ltd Tokyo [In Japanese]
10. Liver Cancer Study Group of Japan General rules for the clinical and pathological study of primary liver cancer 2nd English ed. 2003 Kanehara & Co., Ltd. Tokyo
11. A. Nanashima Y. Sumida S. Morino et. al. The Japanese integrated staging score using liver damage grade for hepatocellular carcinoma in patients after hepatectomy Eur J Surg Oncol 30 2004 765-770
12. K. Omagari S. Honda Y. Kadokawa et. al. Preliminary analysis of a newly proposed prognostic scoring system (SLiDe score) for hepatocellular carcinoma J Gastroenterol Hepatol 19 2004 805-811
13. D.B. Hunton J.L. Bollman H.N. Hoffman Hepatic removal of indocyanine green Mayo Clin Proc 35 1960 752-755
14. A. Nanashima H. Yamaguchi S. Shibasaki et. al. Relationship between indocyanine green test and technetium-99m galactosyl serum albumin scintigraphy in patients scheduled for hepatectomy: Clinical evaluation and patient outcome Hepatol Res 2004 184-190
15. 99mTc-Mebrofenin scintigraphy with indocyanine green clearance test Liver Int 24 2004 117-123
16. Y. Watanabe K. Kumon Assessment by pulse dye-densitometry indocyanine green (ICG) clearance test of hepatic function of patients before cardiac surgery: Its value as a predictor of serious postoperative liver dysfunction J Cardiothorac Vasc Anesth 13 1999 299-303
17. P.S. Kamath R.H. Wiesner M. Malinchoc et. al. A model to predict survival in patients with end-stage liver disease Hepatology 33 2001 464-470